Human-in-the-loop models could provide a credible and scalable path forward for using agentic AI in biopharma commercial ...

Large pharmaceutical firm Novartis confirmed that it is halting and investigating several clinical trial programs involving ...

Eli Lilly will acquire Merida Biosciences for up to $2.875 billion, gaining MER511, a Phase I therapy targeting ...

Large-scale validation of regenerative medicine, especially based on cell therapies, may come from cell therapies developed ...

Amid proliferation of digital platforms for documentation and process execution, biopharma companies are exploring new ...

Earlier this week, it was confirmed that a $380 million partnership between Bristol Myers Squibb (BMS) and contract ...

Argentine biotech firm Biosidus tripled its cell culture capacity with a $12.9 million expansion to boost biosimilar ...

Genentech will invest $750 million in a fill-finish facility in Oregon, reached a construction milestone in North Carolina, ...

Bristol Myers Squibb subsidiary RayzeBio has committed to building a radiopharmaceutical manufacturing facility in Whitestown ...

Industry expert Charley Maxwell shares essential strategies for biotech companies navigating Europe's fragmented regulatory ...

Dare To Use Preparative Chromatography at Industrial Scale for Your API: Maximize Purity, Efficiency, and Sustainability ...

An expert from CTMC told BioProcess International how recent projects in Houston speak to the city’s drive to become a ...